BARCLAYS PLC - AVADEL PHARMACEUTICALS PLC ownership

AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 1 filers reported holding AVADEL PHARMACEUTICALS PLC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of AVADEL PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2023$0
-100.0%
48
-99.9%
0.00%
-100.0%
Q2 2023$813
-18.7%
49,335
+31935.7%
0.00%
Q3 2021$1,000
-75.0%
154
-78.2%
0.00%
Q2 2021$4,000
-96.9%
708
-95.0%
0.00%
Q1 2021$130,000
+36.8%
14,303
+0.6%
0.00%
Q4 2020$95,000
+33.8%
14,215
+1.4%
0.00%
Q3 2020$71,000
-78.4%
14,015
-65.5%
0.00%
Q2 2020$328,000
+195.5%
40,615
+189.1%
0.00%
Q1 2020$111,00014,049
+200600.0%
0.00%
Q1 2019$07
-90.8%
0.00%
Q4 2018$0
-100.0%
76
-65.6%
0.00%
Q3 2018$1,000
-88.9%
221
-85.5%
0.00%
Q2 2018$9,000
-83.0%
1,521
-79.4%
0.00%
Q1 2018$53,000
-13.1%
7,371
-2.6%
0.00%
Q4 2017$61,000
+41.9%
7,570
+86.2%
0.00%
Q3 2017$43,000
+26.5%
4,065
+32.6%
0.00%
Q2 2017$34,0003,065
+4615.4%
0.00%
Q1 2017$0650.00%
Other shareholders
AVADEL PHARMACEUTICALS PLC shareholders Q4 2023
NameSharesValueWeighting ↓
Asymmetry Capital Management, L.P. 520,830$2,625,0001.69%
COWEN AND COMPANY, LLC 1,905,990$9,606,0001.57%
Ghost Tree Capital, LLC 825,000$4,158,0001.20%
GENDELL JEFFREY L 1,115,211$5,621,0001.18%
Vivo Capital, LLC 3,526,093$17,772,0001.03%
ACUTA CAPITAL PARTNERS, LLC 705,218$3,554,0000.96%
RTW INVESTMENTS, LP 5,366,705$27,048,0000.65%
BRANDES INVESTMENT PARTNERS, LP 2,840,669$14,317,0000.50%
Avoro Capital Advisors LLC 4,200,000$21,168,0000.30%
HighVista Strategies LLC 57,495$290,0000.21%
View complete list of AVADEL PHARMACEUTICALS PLC shareholders